minimal Common Oncology Data Elements (mCODE) Implementation Guide
2.0.0 - STU 2

This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.0.0: STU 2) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 4.0.0. For a full list of available versions, see the Directory of published versions

ValueSet: Elixhauser Coagulation Deficiency Value Set

Summary

Defining URL:http://hl7.org/fhir/us/mcode/ValueSet/elixhauser-coagulation-deficiency-vs
Version:2.0.0
Name:ElixhauserCoagulationDeficiencyVS
Title:Elixhauser Coagulation Deficiency Value Set
Status:Active as of 1/18/22 3:17 AM
Definition:

Elixhauser Comorbid Condition Value Set for Coagulation Deficiency. ICD-10 codes are drawn from https://www.hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/comorbidity_icd10.jsp, version 2021.1

Publisher:HL7 International Clinical Interoperability Council
Source Resource:XML / JSON / Turtle

References

Logical Definition (CLD)

  • Include these codes as defined in http://hl7.org/fhir/sid/icd-10-cm
    CodeDisplay
    D61.09Other constitutional aplastic anemia
    D61.1Drug-induced aplastic anemia
    D61.2Aplastic anemia due to other external agents
    D61.3Idiopathic aplastic anemia
    D61.810Antineoplastic chemotherapy induced pancytopenia
    D61.811Other drug-induced pancytopenia
    D61.818Other pancytopenia
    D61.82Myelophthisis
    D61.89Oth aplastic anemias and other bone marrow failure syndromes
    D61.9Aplastic anemia, unspecified
    D65Disseminated intravascular coagulation
    D66Hereditary factor VIII deficiency
    D67Hereditary factor IX deficiency
    D68.0Von Willebrand's disease
    D68.1Hereditary factor XI deficiency
    D68.2Hereditary deficiency of other clotting factors
    D68.311Acquired hemophilia
    D68.312Antiphospholipid antibody with hemorrhagic disorder
    D68.318Oth hemorrhagic disord d/t intrns circ anticoag,antib,inhib
    D68.32Hemorrhagic disord d/t extrinsic circulating anticoagulants
    D68.4Acquired coagulation factor deficiency
    D68.8Other specified coagulation defects
    D68.9Coagulation defect, unspecified
    D69.1Qualitative platelet defects
    D69.3Immune thrombocytopenic purpura
    D69.41Evans syndrome
    D69.42Congenital and hereditary thrombocytopenia purpura
    D69.49Other primary thrombocytopenia
    D69.51Posttransfusion purpura
    D69.59Other secondary thrombocytopenia
    D69.6Thrombocytopenia, unspecified
    D69.8Other specified hemorrhagic conditions
    D69.9Hemorrhagic condition, unspecified
    D75.82Heparin induced thrombocytopenia (HIT)
    O99.111Oth dis of bld/bld-form org/immun mechnsm comp preg, 1st tri
    O99.112Oth dis of bld/bld-form org/immun mechnsm comp preg, 2nd tri
    O99.113Oth dis of bld/bld-form org/immun mechnsm comp preg, 3rd tri
    O99.119Oth dis of bld/bld-form org/immun mechnsm comp preg,unsp tri
    O99.12Oth dis of the bld/bld-form org/immun mechnsm comp chldbrth
    O99.13Oth dis of the bld/bld-form org/immun mechnsm comp the puerp

 

Expansion

This value set contains 40 concepts

Expansion based on http://hl7.org/fhir/sid/icd-10-cm version 2021

All codes in this table are from the system http://hl7.org/fhir/sid/icd-10-cm

CodeDisplay
D61.09Other constitutional aplastic anemia
D61.1Drug-induced aplastic anemia
D61.2Aplastic anemia due to other external agents
D61.3Idiopathic aplastic anemia
D61.810Antineoplastic chemotherapy induced pancytopenia
D61.811Other drug-induced pancytopenia
D61.818Other pancytopenia
D61.82Myelophthisis
D61.89Oth aplastic anemias and other bone marrow failure syndromes
D61.9Aplastic anemia, unspecified
D65Disseminated intravascular coagulation
D66Hereditary factor VIII deficiency
D67Hereditary factor IX deficiency
D68.0Von Willebrand's disease
D68.1Hereditary factor XI deficiency
D68.2Hereditary deficiency of other clotting factors
D68.311Acquired hemophilia
D68.312Antiphospholipid antibody with hemorrhagic disorder
D68.318Oth hemorrhagic disord d/t intrns circ anticoag,antib,inhib
D68.32Hemorrhagic disord d/t extrinsic circulating anticoagulants
D68.4Acquired coagulation factor deficiency
D68.8Other specified coagulation defects
D68.9Coagulation defect, unspecified
D69.1Qualitative platelet defects
D69.3Immune thrombocytopenic purpura
D69.41Evans syndrome
D69.42Congenital and hereditary thrombocytopenia purpura
D69.49Other primary thrombocytopenia
D69.51Posttransfusion purpura
D69.59Other secondary thrombocytopenia
D69.6Thrombocytopenia, unspecified
D69.8Other specified hemorrhagic conditions
D69.9Hemorrhagic condition, unspecified
D75.82Heparin induced thrombocytopenia (HIT)
O99.111Oth dis of bld/bld-form org/immun mechnsm comp preg, 1st tri
O99.112Oth dis of bld/bld-form org/immun mechnsm comp preg, 2nd tri
O99.113Oth dis of bld/bld-form org/immun mechnsm comp preg, 3rd tri
O99.119Oth dis of bld/bld-form org/immun mechnsm comp preg,unsp tri
O99.12Oth dis of the bld/bld-form org/immun mechnsm comp chldbrth
O99.13Oth dis of the bld/bld-form org/immun mechnsm comp the puerp

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code